SEC Form 4 · accession 0001127602-18-015505
CONMED Corp · CNMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Nathan Folkert
Officer — VP GM Orthopedics
Period of report
Apr 27, 2018
Accepted (ET)
Apr 30, 2018 · 2:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000816956
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 27, 2018 | M | 296 | $41.93 | A | 1,264 | D | |
| Common Stock | Apr 27, 2018 | M | 4,113 | $39.87 | A | 5,377 | D | |
| Common StockF1 | Apr 27, 2018 | S | 4,409 | $64.98 | D | 968 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options To Purchase Common StockF2 | $41.93 | Apr 27, 2018 | M | 296 | D | — | Mar 1, 2027 | Common Stock | 296 | 35,704 | D |
| Options To Purchase Common StockF2 | $39.87 | Apr 27, 2018 | M | 4,113 | D | — | Mar 1, 2026 | Common Stock | 4,113 | 33,887 | D |
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.92 to $65.01. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
- F2The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period